{"id":"https://openalex.org/W2560183317","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.10096","title":"The role of E-cadherin expression in response and outcome in patients with leiomyosarcoma treated with chemotherapy.","display_name":"The role of E-cadherin expression in response and outcome in patients with leiomyosarcoma treated with chemotherapy.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2560183317","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.10096","mag":"2560183317"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.10096","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.10096","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.10096","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054595254","display_name":"Vinod Ravi","orcid":"https://orcid.org/0000-0001-6080-9336","observed_orcids":["https://orcid.org/0000-0001-6080-9336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Ravi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017563853","display_name":"Jie Yang","orcid":"https://orcid.org/0000-0001-7358-4586","observed_orcids":["https://orcid.org/0000-0001-7358-4586"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014340135","display_name":"Dejka M. Araujo","orcid":"https://orcid.org/0000-0002-1223-6542","observed_orcids":["https://orcid.org/0000-0002-1223-6542"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. M. Araujo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040323780","display_name":"M. S. Park","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. S. Park","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046099119","display_name":"Robert S. Benjamin","orcid":"https://orcid.org/0000-0002-2589-5870","observed_orcids":["https://orcid.org/0000-0002-2589-5870"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. S. Benjamin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029325260","display_name":"W. Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W. Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004418792","display_name":"Jonathan C. Trent","orcid":"https://orcid.org/0000-0001-6169-5238","observed_orcids":["https://orcid.org/0000-0001-6169-5238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. C. Trent","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021769842","display_name":"Sheetal Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"10096","last_page":"10096"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10989","display_name":"Uterine Myomas and Treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11485","display_name":"Gastrointestinal Tumor Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leiomyosarcoma","display_name":"leiomyosarcoma","score":0.9359999895095825},{"id":"https://openalex.org/keywords/e-cadherin","display_name":"E-cadherin","score":0.9079999923706055},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8410000205039978},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.9449999928474426},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8370000123977661},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mesenchymal-epithelial-transition","display_name":"mesenchymal-epithelial transition","score":0.9399999976158142},{"id":"https://openalex.org/keywords/tumor-markers","display_name":"tumor markers","score":0.5410000085830688},{"id":"https://openalex.org/keywords/uterine-leiomyosarcoma","display_name":"uterine leiomyosarcoma","score":0.7860000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8440374135971069},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8438840508460999},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6335681676864624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5906159281730652},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5511776208877563},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5331003069877625},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.5137882828712463},{"id":"https://openalex.org/C2777532014","wikidata":"https://www.wikidata.org/wiki/Q1504713","display_name":"Leiomyosarcoma","level":2,"score":0.4447517693042755},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34637266397476196},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3191661536693573}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.10096","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.10096","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.10096","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1970843418","https://openalex.org/W2144635032","https://openalex.org/W2065290681","https://openalex.org/W4319320312","https://openalex.org/W2769136711","https://openalex.org/W3061067356","https://openalex.org/W2019765540","https://openalex.org/W4200325227","https://openalex.org/W2368431660","https://openalex.org/W2257690489"],"abstract_inverted_index":{"10096":[0],"Background:":[1],"Leiomyosarcoma":[2],"(LMS)":[3],"is":[4],"a":[5],"mesenchymal":[6],"neoplasm":[7],"showing":[8],"smooth":[9],"muscle":[10],"differentiation":[11],"commonly":[12],"occurring":[13],"in":[14,29,69,248],"the":[15,32,48,64,181,189,206,228,241],"uterus,":[16],"blood":[17],"vessels":[18],"and":[19,31,38,53,57,83,93,112,140,164,185,232],"GI":[20],"tract.":[21],"We":[22,62],"have":[23],"previously":[24],"demonstrated":[25],"mesenchymal-to-epithelial":[26],"reverting":[27],"transition":[28],"LMS":[30,71,249],"correlation":[33],"between":[34,50,158,205],"tumor":[35,76,159],"E-cadherin":[36,51,67,131,145,165,182,190,229,242,246],"expression":[37,52,68,166,247],"improved":[39,252],"overall":[40,113],"survival":[41,104,114,218],"(OS).":[42,115],"In":[43],"this":[44],"study":[45],"we":[46],"investigate":[47],"relationship":[49,157],"response":[54,110,211,258],"to":[55,200,259],"doxorubicin-":[56,121],"gemcitabine-based":[58,123,175,201],"chemotherapy":[59,124],"regimens.":[60],"Methods:":[61],"analyzed":[63],"presence":[65],"of":[66,86],"31":[70],"samples":[72],"from":[73],"our":[74],"institutional":[75],"bank":[77],"using":[78],"reverse-phase":[79],"protein":[80],"lysate":[81],"array":[82],"immunohistochemical":[84],"staining":[85],"tissue":[87],"microarray.":[88],"Clinical":[89],"data":[90],"including":[91],"demographics":[92],"treatment":[94],"history":[95],"were":[96,125,203],"collected.":[97],"Primary":[98],"outcome":[99,107],"measure":[100],"was":[101,167,177,197,219],"progression":[102],"free":[103],"(PFS);":[105],"secondary":[106],"measures":[108],"included":[109],"rate":[111],"Results:":[116],"Twenty-six":[117],"patients":[118,129,143,172],"who":[119],"received":[120],"or":[122],"identified.":[126],"Sixteen":[127],"(62%)":[128],"had":[130,144],"positive":[132,183,230],"tumors":[133,147],"(M:F":[134,148],"=":[135,149],"4:12;":[136],"median":[137,151],"age":[138,152],"52),":[139],"ten":[141],"(38%)":[142],"negative":[146,191,243],"2:8;":[150],"50).":[153],"No":[154],"statistically":[155],"significant":[156],"site":[160],"(uterine":[161],"vs.":[162],"non-uterine)":[163],"found.":[168],"Median":[169],"PFS":[170],"for":[171,180,188,227,240],"treated":[173],"with":[174,251],"therapy":[176,202],"14":[178],"months":[179,187,221,234],"group":[184,231],"9":[186],"group,":[192],"but":[193,254],"no":[194],"statistical":[195],"significance":[196],"reached.":[198],"Responses":[199],"similar":[204],"two":[207],"groups":[208],"(40%":[209],"partial":[210],"(PR)":[212],"vs":[213],"40":[214],"%":[215],"PR).":[216],"Overall":[217],"59":[220],"(95%":[222,235],"CI":[223,236],"55.8":[224],"\u2013":[225,238],"186.0)":[226],"25":[233],"23.7":[237],"69.9)":[239],"group.":[244],"Conclusions:":[245],"correlates":[250],"OS":[253],"does":[255],"not":[256],"predict":[257],"chemotherapy.":[260]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-12-16T00:00:00"}